newsfilter
← Latest News
Business Wire·

Humanigen to Present at Investor Conferences January 7 and 13, 2022

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced that Cameron Durrant, chairman and chief executive officer of Humani